KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) Other Operating Expenses (2016 - 2026)

Synopsys (SNPS) has disclosed Other Operating Expenses for 17 consecutive years, with $552.4 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses rose 159.09% year-over-year to $552.4 million, compared with a TTM value of $1.6 billion through Jan 2026, up 85.35%, and an annual FY2025 reading of $1.1 billion, up 53.62% over the prior year.
  • Other Operating Expenses was $552.4 million for Q1 2026 at Synopsys, up from $546.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $552.4 million in Q1 2026 and bottomed at $22.7 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $256.2 million, with a median of $218.3 million recorded in 2023.
  • Peak annual rise in Other Operating Expenses hit 881.98% in 2024, while the deepest fall reached 26.7% in 2024.
  • Year by year, Other Operating Expenses stood at $206.4 million in 2022, then tumbled by 88.98% to $22.7 million in 2023, then surged by 881.98% to $223.3 million in 2024, then surged by 144.7% to $546.4 million in 2025, then grew by 1.08% to $552.4 million in 2026.
  • Business Quant data shows Other Operating Expenses for SNPS at $552.4 million in Q1 2026, $546.4 million in Q4 2025, and $288.1 million in Q3 2025.